Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Uni-Bio Science Group achieves key milestones with a new collagen dressing approval and a skincare product launch.

flag Uni-Bio Science Group has achieved two major milestones in the medical aesthetics market. flag The company received approval for its recombinant collagen dressing as a Class II medical device and launched "肌顏態®," a new medical aesthetics product. flag These innovations, which aim to enhance skin quality and repair, have garnered attention from dermatologists and reflect the company's commitment to innovation and market growth. flag The medical aesthetics market is projected to be worth over RMB 600 billion by 2030.

4 Articles